ClearBridge Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-830,668
Closed -$126M 769
2022
Q3
$126M Sell
830,668
-108
-0% -$16.3K 0.13% 163
2022
Q2
$121M Sell
830,776
-321,053
-28% -$46.8M 0.11% 176
2022
Q1
$137M Buy
1,151,829
+279,259
+32% +$33.1M 0.1% 192
2021
Q4
$120M Buy
872,570
+794
+0.1% +$109K 0.08% 222
2021
Q3
$121M Sell
871,776
-2,538
-0.3% -$353K 0.09% 207
2021
Q2
$84.9M Buy
874,314
+116,974
+15% +$11.4M 0.06% 265
2021
Q1
$51.8M Buy
757,340
+223,709
+42% +$15.3M 0.04% 341
2020
Q4
$45.7M Buy
533,631
+164,475
+45% +$14.1M 0.04% 343
2020
Q3
$24M Buy
369,156
+89,811
+32% +$5.84M 0.02% 395
2020
Q2
$20.4M Buy
+279,345
New +$20.4M 0.02% 408